重组Anti-IRF7抗体[EPR23509-21]
Anti-IRF7 antibody [EPR23509-21]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal IRF7 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 7 publications.
查看别名
Interferon regulatory factor 7, IRF-7, IRF7
- IP
Lab
Immunoprecipitation - Anti-IRF7 antibody [EPR23509-21] (AB238137)
IRF7 was immunoprecipitated from 0.35 mg of Jurkat (treated with 100 nM IFN alpha for 18 hours, then added 10 μM MG-132 for another 6 hours) whole cell lysate with ab238137 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab238137 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : Jurkat (treated as above) whole cell lysate 10 μg (Input).
Lane 2 : ab238137 IP in Jurkat (treated as above) whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab238137 in Jurkat (treated as above) whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 84 seconds.
65-kDa full length IRF7 and 45-kDa C-terminal cleaved IRF7 are observed (PMID : 23175366).
All lanes:
Immunoprecipitation - Anti-IRF7 antibody [EPR23509-21] (ab238137)
Predicted band size: 54 kDa
Observed band size: 45 kDa,65 kDa
false
- WB
Lab
Western blot - Anti-IRF7 antibody [EPR23509-21] (AB238137)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 37 seconds.
The expression of IRF7 is induced by IFN alpha in Jurkat (PMID : 9786932).
65-kDa full length IRF7 and 45-kDa C-terminal cleaved IRF7 are observed (PMID : 23175366).
All lanes:
Western blot - Anti-IRF7 antibody [EPR23509-21] (ab238137) at 1/5000 dilution
Lane 1:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 2:
Jurkat treated with 100 nM IFN alpha for 18 hours, then added 10 μM MG-132 for another 6 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 45 kDa,65 kDa
false
不同偶联物与剂型 (1)
-
Anti-IRF7 antibody [EPR23509-21] - BSA and Azide free
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IRF7 activates and modulates the expression of type I interferons and other cytokines important for antiviral defense. This protein can form part of a larger complex with other IRF family members to enhance its effect on gene transcription. IRF7 operates through its interaction with transcriptional coactivators allowing it to execute its function as a transcriptional activator reinforcing the immune system's response to infectious agents.
Pathways
IRF7 plays a critical role in the Toll-like receptor (TLR) signaling pathway and retinoic acid-inducible gene I (RIG-I) pathway. It directly interacts with MyD88 and IRAK1 proteins linking it to signal transduction pathways that lead to interferon-beta production. The activation of IRF7 in these pathways also strengthens the body's defense mechanism by enhancing the transcription of antiviral genes forming a robust antibacterial and antiviral environment within the host.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 44:116166 PubMed40833856
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 14:e1799 PubMed39118300
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer communications (London, England) 44:408-432 PubMed38407943
2024
Applications
Unspecified application
Species
Unspecified reactive species
Poultry science 103:103274 PubMed38043405
2023
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 14: PubMed36366509
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 31:1165-1176 PubMed35332586
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 7: PubMed33863728
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com